{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:47:13Z","timestamp":1788306433637,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1054\/ghir.2000.0175","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T10:55:42Z","timestamp":1032432942000},"page":"306-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Safety issues in children and adolescents during growth hormone therapy\u2014a review"],"prefix":"10.1054","volume":"10","author":[{"given":"Peter E.","family":"Clayton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoher T.","family":"Cowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1054\/ghir.2000.0175_RF1","first-page":"83","article-title":"Water and sodium retention during short-term administration of growth hormone to short normal children","volume":"50","author":"Lampit","year":"1998","journal-title":"Horm Res"},{"key":"10.1054\/ghir.2000.0175_RF2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2265.1993.tb01002.x","article-title":"Blood pressure and the renin-angiotensin-aldosterone system in children receiving recombinant human growth hormone","volume":"38","author":"Barton","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1054\/ghir.2000.0175_RF3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM199308263290917","article-title":"Growth hormone, insulin-like growth factor I, and benign intracranial hypertension [letter]","volume":"329","author":"Malozowski","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1054\/ghir.2000.0175_RF4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0022-3476(95)70232-6","article-title":"Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone","volume":"126","author":"Malozowski","year":"1995","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1651-2227.1998.tb01463.x","article-title":"Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand","volume":"87","author":"Crock","year":"1998","journal-title":"Acta Paediatr Suppl."},{"key":"10.1054\/ghir.2000.0175_RF6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s004670050315","article-title":"Papilledema in 15 renally compromised patients treated with growth hormone","volume":"11","author":"Koller","year":"1997","journal-title":"Pediatric Nephrology"},{"key":"10.1054\/ghir.2000.0175_RF7","first-page":"1704","article-title":"Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience","volume":"81","author":"Blethen","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1651-2227.1997.tb14826.x","article-title":"Non-organic failure to thrive complicated by benign intracranial hypertension during catch-up growth","volume":"86","author":"Alison","year":"1997","journal-title":"Acta Paediatr Suppl"},{"key":"10.1054\/ghir.2000.0175_RF9","series-title":"Progress in Growth Hormone Therapy\u201410 years of KIGS","first-page":"349","article-title":"Adverse events during GH treatment: 10 years\u2019 experience in KIGS, a Pharmacoepidemiological Survey","author":"Wilton","year":"1999"},{"key":"10.1054\/ghir.2000.0175_RF10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2265.1989.tb00431.x","article-title":"The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects","volume":"30","author":"Ho","year":"1989","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1054\/ghir.2000.0175_RF11","first-page":"320","article-title":"Thyroid function in non-growth hormone-deficient short children during a placebo-controlled double blind trial of recombinant growth hormone therapy","volume":"80","author":"Rose","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-3476(05)81190-4","article-title":"Growth and thyroid function in children treated with growth hormone","volume":"121","author":"Pirazzoli","year":"1992","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF13","first-page":"3115","article-title":"Metabolic consequences of 5-year growth hormone (GH) therapy in children treated with GH for idiopathic short stature. Genentech Collaborative Study Group","volume":"83","author":"Saenger","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s004310050563","article-title":"The influence of growth hormone monotherapy and growth hormone in combination with oxandrolone or testosterone on thyroxid hormone parameters and thyroxine binding globulin in patients with Ullrich-Turner syndrome","volume":"156","author":"Schmitt","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0022-3476(05)81191-6","article-title":"Nocturnal thyrotropin surge in growth hormone-deficient children","volume":"121","author":"Municchi","year":"1992","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000182186","article-title":"Growth hormone and lipids","volume":"1","author":"Keller","year":"1991","journal-title":"Horm Res 36 Suppl"},{"key":"10.1054\/ghir.2000.0175_RF17","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/ajcn\/50.6.1348","article-title":"Metabolic effects of a single administration of growth hormone on lipid and carbohydrate metabolism in normal-weight and obese subjects","volume":"50","author":"Seng","year":"1989","journal-title":"Am J Clin Nutr"},{"key":"10.1054\/ghir.2000.0175_RF18","first-page":"356","article-title":"The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance","volume":"80","author":"Beshyah","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00005792-199001000-00004","article-title":"Long-term follow-up of hypopituitary patients treated with human growth hormone","volume":"69","author":"Libber","year":"1990","journal-title":"Medicine"},{"key":"10.1054\/ghir.2000.0175_RF20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.0.1340061","article-title":"An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency","volume":"134","author":"Garry","year":"1996","journal-title":"Eur J Endocrinol."},{"key":"10.1054\/ghir.2000.0175_RF21","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0026-0495(94)90001-9","article-title":"Lipids and apolipoproteins in growth hormone-deficient children during treatment","volume":"43","author":"Schaefer","year":"1994","journal-title":"Metabolism: Clinical & Experimental"},{"key":"10.1054\/ghir.2000.0175_RF22","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1210\/jcem.74.4.1548357","article-title":"Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group","volume":"74","author":"De Muinck","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF23","first-page":"3890","article-title":"Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects","volume":"83","author":"Kuromaru","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-3476(88)80057-X","article-title":"Carbohydrate and lipid metabolism in Turner syndrome: effect of therapy with growth hormone, oxandrolone, and a combination of both","volume":"112","author":"Wilson","year":"1988","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF25","first-page":"S128","article-title":"A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant","volume":"53","author":"Hokken-Koelega","year":"1996","journal-title":"Kidney Int"},{"key":"10.1054\/ghir.2000.0175_RF26","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0026-0495(97)90153-0","article-title":"Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner\u2019s syndrome","volume":"46","author":"Monti","year":"1997","journal-title":"Metabolism: Clinical & Experimental"},{"key":"10.1054\/ghir.2000.0175_RF27","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1210\/jcem.84.5.5685","article-title":"Mediation of the hepatic effects of growth hormone by its lipolytic activity","volume":"84","author":"Piatti","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/jcem-69-2-253","article-title":"Growth hormone treatment of children with short stature increases insulin secretion but does not impair glucose disposal","volume":"69","author":"Walker","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF29","first-page":"236","article-title":"Carbohydrate metabolism on high dose growth hormone therapy in children treated for leukaemia","volume":"25","author":"Crawford","year":"1989","journal-title":"Australian Paediatric Journal"},{"key":"10.1054\/ghir.2000.0175_RF30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00866753","article-title":"Carbohydrate metabolism in children receiving growth hormone for 5 years. Chronic renal insufficiency compared with growth hormone deficiency, Turner syndrome, and idiopathic short stature","volume":"10","author":"Saenger","year":"1996","journal-title":"Genentech Collaborative Group. Pediatric Nephrology."},{"key":"10.1054\/ghir.2000.0175_RF31","first-page":"601","article-title":"The effectiveness of recombinant growth hormone in height deficiency due to intrauterine growth retardation, (Spanish)","volume":"112","author":"Vicens-Calvet","year":"1999","journal-title":"Medicina Clinica."},{"key":"10.1054\/ghir.2000.0175_RF32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000182687","article-title":"Growth and metabolic data following growth hormone treatment of children with intrauterine growth retardation","volume":"39","author":"Albanese","year":"1993","journal-title":"Horm Res"},{"key":"10.1054\/ghir.2000.0175_RF33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2265.1998.00502.x","article-title":"Effect of long-term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency","volume":"49","author":"Seminara","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1054\/ghir.2000.0175_RF34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000182692","article-title":"Glucose metabolism in Ullrich Turner syndrome: long-term effects of therapy with human growth hormone. German Lilly UTS Study Group","volume":"39","author":"Weise","year":"1993","journal-title":"Horm Res"},{"key":"10.1054\/ghir.2000.0175_RF35","first-page":"769","article-title":"Carbohydrate metabolism during long term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study","volume":"85","author":"Sas","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF36","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(99)04055-6","article-title":"Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment","volume":"355","author":"Cutfield","year":"2000","journal-title":"Lancet"},{"key":"10.1054\/ghir.2000.0175_RF37","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0022-3476(96)80124-7","article-title":"Increased incidence of non-insulin-dependent diabetes mellitus among adolescents [see comments]","volume":"128","author":"Pinhas-Hamiel","year":"1996","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF38","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/0168-8227(94)90221-6","article-title":"Epidemiology of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in Japanese children. [Review] [17 refs]","volume":"24 Suppl","author":"Kitagawa","year":"1994","journal-title":"Diabetes Research & Clinical Practice."},{"key":"10.1054\/ghir.2000.0175_RF39","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0022-3476(05)80959-X","article-title":"Symptomatic non-insulin-dependent diabetes mellitus during therapy with recombinant human growth hormone [see comments]","volume":"123","author":"Botero","year":"1993","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1515\/JPEM.1995.8.4.243","article-title":"Adverse events during growth hormone therapy","volume":"8","author":"Cowell","year":"1995","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF41","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(88)91968-X","article-title":"Leukemia in patients treated with growth hormone","volume":"1","author":"Watanabe","year":"1988","journal-title":"Lancet"},{"key":"10.1054\/ghir.2000.0175_RF42","first-page":"1159","article-title":"Leukemia in patients treated with growth hormone","author":"Fisher","year":"1988","journal-title":"Lancet"},{"key":"10.1054\/ghir.2000.0175_RF43","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/jcem.84.6.5716","article-title":"Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan","volume":"84","author":"Nishi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3476(98)70245-8","article-title":"Growth hormone replacement and the risk of malignancy in children with neurofibromatosis [see comments]","volume":"133","author":"Howell","year":"1998","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archpedi.1985.02140060029020","article-title":"Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism","volume":"139","author":"Arslanian","year":"1985","journal-title":"Am J Dis Child"},{"key":"10.1054\/ghir.2000.0175_RF46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(87)90355-2","article-title":"Does growth hormone cause relapse of brain tumours?","volume":"1","author":"Clayton","year":"1987","journal-title":"Lancet"},{"key":"10.1054\/ghir.2000.0175_RF47","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/bmj.304.6842.1601","article-title":"Growth hormone and tumour recurrence [see comments]","volume":"304","author":"Ogilvy-Stuart","year":"1992","journal-title":"BMJ"},{"key":"10.1054\/ghir.2000.0175_RF48","series-title":"Progress in Growth Hormone Therapy \u2013 5 years of KIGS","first-page":"291","article-title":"Adverse events during growth hormone treatment: 5 year\u2019s experience in the Kabi International Growth Study","author":"Wilton","year":"1994"},{"key":"10.1054\/ghir.2000.0175_RF49","first-page":"1416","article-title":"Lack of increased risk for extracranial, nonleukemic neoplasms in recipients of recombinant deoxyribonucleic acid growth hormone","volume":"80","author":"Tuffli","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF50","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0022-3476(96)70002-1","article-title":"Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience","volume":"128","author":"Moshang","year":"1996","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF51","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0022-3476(97)70008-8","article-title":"Risk of leukemia in children treated with human growth hormone: review and reanalysis","volume":"131","author":"Allen","year":"1997","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/eje.0.1330635","article-title":"Effects of growth hormone and insulin-like growth factor I on the immune system. [Review] [137 refs]","volume":"133","author":"Auernhammer","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2000.0175_RF53","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1073\/pnas.88.6.2274","article-title":"The pituitary gland is required for protection against lethal effects of Salmonella typhimurium","volume":"88","author":"Edwards","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1054\/ghir.2000.0175_RF54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000185026","article-title":"Use of human recombinant growth hormone and human recombinant insulin-like growth factor-I in patients with human immunodeficiency virus infection","volume":"46","author":"Hirschfeld","year":"1996","journal-title":"Horm Res"},{"key":"10.1054\/ghir.2000.0175_RF55","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(98)07546-1","article-title":"The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease","volume":"353","author":"Hattersley","year":"1999","journal-title":"Lancet"},{"key":"10.1054\/ghir.2000.0175_RF56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/1523-1747.ep12616668","article-title":"Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin","volume":"99","author":"Tavakkol","year":"1992","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1054\/ghir.2000.0175_RF57","first-page":"1919","article-title":"Up-regulation of growth hormone receptor immunoreactivity in human melanoma","volume":"19","author":"Lincoln","year":"1999","journal-title":"Anticancer Research"},{"key":"10.1054\/ghir.2000.0175_RF58","first-page":"3335","article-title":"Growth hormone deficiency and hyperthermia during exercise: a controlled study of sixteen GH-deficient patients","volume":"80","author":"Juul","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF59","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/jsre.1995.1046","article-title":"Dose-response study of the effect of growth hormone on mechanical properties of skin graft wounds","volume":"58","author":"Jorgensen","year":"1995","journal-title":"J Surg Res"},{"key":"10.1054\/ghir.2000.0175_RF60","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004630-199707000-00002","article-title":"Insulin-like growth factor-I liposomal gene transfer and systemic growth hormone stimulate wound healing","volume":"18","author":"Pierre","year":"1997","journal-title":"Journal of Burn Care & Rehabilitation"},{"key":"10.1054\/ghir.2000.0175_RF61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00000658-199407000-00004","article-title":"Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns","volume":"220","author":"Gilpin","year":"1994","journal-title":"Ann Surg"},{"key":"10.1054\/ghir.2000.0175_RF62","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/0140-6736(93)90636-U","article-title":"Effects of human growth hormone therapy on melanocytic naevi","volume":"341","author":"Bourguignon","year":"1993","journal-title":"Lancet"},{"key":"10.1054\/ghir.2000.0175_RF63","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1365-2133.1998.02265.x","article-title":"Influence of genetic and environmental factors on melanocytic naevi: a lesson from Turner\u2019s syndrome","volume":"138","author":"Zvulunov","year":"1998","journal-title":"British Journal of Dermatology"},{"key":"10.1054\/ghir.2000.0175_RF64","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2133.1997.tb03784.x","article-title":"Lack of effect of growth hormone therapy on the count and density of melanocytic naevi in children","volume":"137","author":"Zvulunov","year":"1997","journal-title":"British Journal of Dermatology"},{"key":"10.1054\/ghir.2000.0175_RF65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000126813","article-title":"Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters","volume":"61","author":"Johansson","year":"1995","journal-title":"Neuroendocrinology"},{"key":"10.1054\/ghir.2000.0175_RF66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF01813557","article-title":"Medulloblastoma in childhood","volume":"50","author":"Raimondi","year":"1979","journal-title":"Acta Neurochirurgica"},{"key":"10.1054\/ghir.2000.0175_RF67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1651-2227.1993.tb12518.x","article-title":"A community-based prospective incidence study of epileptic seizures in children","volume":"82","author":"Sidenvall","year":"1993","journal-title":"Acta Paediatr Suppl"},{"key":"10.1054\/ghir.2000.0175_RF68","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1203\/00006450-196907000-00005","article-title":"Studies on convulsive disorders in young children. I. Incidence of febrile and nonfebrile convulsions by age and other factors","volume":"3","author":"Van der Berg","year":"1969","journal-title":"Pediatric Research"},{"key":"10.1054\/ghir.2000.0175_RF69","first-page":"4622","article-title":"Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial","volume":"84","author":"Sas","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF70","first-page":"437","article-title":"Hip diseases and growth hormone deficiency, (French)","volume":"49","author":"Puel","year":"1992","journal-title":"Archives Francaises de Pediatrie"},{"key":"10.1054\/ghir.2000.0175_RF71","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM196611032751804","article-title":"Incidence of Legg-Perthes disease (osteochondritis deformans)","volume":"275","author":"Molloy","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1054\/ghir.2000.0175_RF72","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/17453678008990874","article-title":"Growth related hormones in idiopathic scoliosis. An endocrine basis for accelerated growth","volume":"51","author":"Skogland","year":"1980","journal-title":"Acta Orthopaedica Scandinavica"},{"key":"10.1054\/ghir.2000.0175_RF73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00007632-198802000-00001","article-title":"Twenty-four-hour growth hormone profiles in pubertal girls with idiopathic scoliosis","volume":"13","author":"Ahl","year":"1988","journal-title":"Spine"},{"key":"10.1054\/ghir.2000.0175_RF74","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00007632-199201000-00016","article-title":"Growth in girls with adolescent idiopathic scoliosis","volume":"17","author":"Hagglund","year":"1992","journal-title":"Spine"},{"key":"10.1054\/ghir.2000.0175_RF75","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/01241398-199711000-00003","article-title":"Scoliosis in patients treated with growth hormone","volume":"17","author":"Wang","year":"1997","journal-title":"Journal of Pediatric Orthopedics"},{"key":"10.1054\/ghir.2000.0175_RF76","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0889-8529(18)30284-6","article-title":"Turner syndrome","volume":"20","author":"Lippe","year":"1991","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1054\/ghir.2000.0175_RF77","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2106\/00004623-197456080-00026","article-title":"Slipped upper femoral epiphysis following treatment with human growth hormone","volume":"56","author":"Fidler","year":"1974","journal-title":"J Bone Joint Surg Am"},{"key":"10.1054\/ghir.2000.0175_RF78","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1302\/0301-620X.56B4.703","article-title":"Slipped femoral capital epiphysis occurring during growth hormone therapy. Report of a case","volume":"56","author":"Rennie","year":"1974","journal-title":"J Bone Joint Surg [Br]"},{"key":"10.1054\/ghir.2000.0175_RF79","first-page":"396","article-title":"Slipped capital femoral epiphysis in growth hormone-deficient patients","volume":"139","author":"Rappaport","year":"1985","journal-title":"Am J Dis Child"},{"key":"10.1054\/ghir.2000.0175_RF80","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/17453676908989514","article-title":"The incidence of slipped capital femoral epiphysis","volume":"40","author":"Henrikson","year":"1969","journal-title":"Acta Orthopaedica Scandinavica"},{"key":"10.1054\/ghir.2000.0175_RF81","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2106\/00004623-197052060-00013","article-title":"The incidence and distribution of slipped capital femoral epiphysis in Connecticut and Southwestern United States","volume":"52","author":"Kelsey","year":"1970","journal-title":"J Bone Joint Surg Am"},{"key":"10.1054\/ghir.2000.0175_RF82","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000182568","article-title":"Epidemiologic survey of patients treated with growth hormone in France in the period 1959\u20131990: preliminary results","volume":"38 (suppl 1)","author":"Job","year":"1992","journal-title":"Horm Res"},{"key":"10.1054\/ghir.2000.0175_RF83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000185006","article-title":"Slipped capital femoral epiphysis in children treated with growth hormone. A summary of the National Cooperative Growth Study experience","volume":"46","author":"Blethen","year":"1996","journal-title":"Horm Res"},{"key":"10.1054\/ghir.2000.0175_RF84","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-3476(99)70136-8","article-title":"Can growth hormone treatment in boys without growth hormone deficiency impair testicular function? [see comments]","volume":"135","author":"Bertelloni","year":"1999","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF85","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1530\/eje.0.1400350","article-title":"Lack of effects of recombinant human GH on spermatogenesis in the adult cynomolgus monkey (Macaca fascicularis)","volume":"140","author":"Sjogren","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.2000.0175_RF86","first-page":"269","article-title":"Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study","volume":"49","author":"Juul","year":"1998","journal-title":"Horm Res"},{"key":"10.1054\/ghir.2000.0175_RF87","first-page":"2","article-title":"Role of growth hormone in ovarian physiology and onset of puberty","volume":"4","author":"Sharara","year":"1997","journal-title":"J Soc Gynecol Invest"},{"key":"10.1054\/ghir.2000.0175_RF88","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1210\/endo.140.6.6992","article-title":"Deficits in female reproductive function in GH-R-KO mice; role of IGF-I","volume":"140","author":"Danilovich","year":"1999","journal-title":"Endocrinology"},{"key":"10.1054\/ghir.2000.0175_RF89","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/diacare.17.6.531","article-title":"The role of growth hormone in the development of diabetic retinopathy [see comments]","volume":"17","author":"Alzaid","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1054\/ghir.2000.0175_RF90","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM197806012982202","article-title":"A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes","volume":"298","author":"Merimee","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1054\/ghir.2000.0175_RF91","first-page":"2380","article-title":"Retinal changes mimicking diabetic retinopathy in two nondiabetic, growth hormone-treated patients","volume":"83","author":"Koller","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.2000.0175_RF92","first-page":"176","article-title":"Factors affecting growth and strategies for treatment in children after renal transplantation","volume":"1","author":"Tonshoff","year":"1997","journal-title":"Pediatric Transplantation"},{"key":"10.1054\/ghir.2000.0175_RF93","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0022-3476(97)70005-2","article-title":"Growth-hormone treatment of renal transplant recipients: the National Cooperative Growth Study experience\u2014a report of the National Cooperative Growth Study and the North American Pediatric Renal Transplant Cooperative Study","volume":"131","author":"Mentser","year":"1997","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF94","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s004670050483","article-title":"Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology","volume":"12","author":"Guest","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1054\/ghir.2000.0175_RF95","first-page":"209","article-title":"Metabolic effects of long-term growth hormone treatment in prepubertal children with chronic renal failure and after kidney transplantation","volume":"43","author":"Haffner","year":"1998","journal-title":"The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Res"},{"key":"10.1054\/ghir.2000.0175_RF96","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0022-3476(99)70170-8","article-title":"The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner\u2019s syndrome. Dutch Working Group on Growth Hormone","volume":"135","author":"Sas","year":"1999","journal-title":"J Pediatr"},{"key":"10.1054\/ghir.2000.0175_RF97","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00008480-199508000-00020","article-title":"Complications of growth hormone therapy in children. [Review] [62 refs]","volume":"7","author":"Blethen","year":"1995","journal-title":"Curr Opin Pediatr"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637400901758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637400901758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:38:01Z","timestamp":1761086281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637400901758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S1096637400901758"],"URL":"https:\/\/doi.org\/10.1054\/ghir.2000.0175","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety issues in children and adolescents during growth hormone therapy\u2014a review","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1054\/ghir.2000.0175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Harcourt Publishers Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}